Heterotopic vs. orthotopic liver transplantation for chronic liver disease: A case-control comparison of short-term and long-term outcomes

Liver Transplantation

Volumn 11, Issue 4, 2005, Pages 396-401

  de Rave, Sjoerd ^a   Hansen, Bettina E ^a   Groenland, Theo H N ^a   Kazemier, Geert ^a   de Man, Robert A ^a   Metselaar, Herold J ^a   Terpstra, Onno T ^a,b   Tilanus, Hugo W ^a   Ijzermans, Jan H N M ^a   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BILIARY TRACT DISEASE; BLOOD COMPATIBILITY; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HETEROTOPIC TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; MALE; MORTALITY; ORTHOTOPIC TRANSPLANTATION; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHRONIC DISEASE; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 20244364950     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20376     Document Type: Article

References (11)

1. Terpstra OT, Schalm SW, Weimar W, Willemse PJA, Baumgartner D, Groenland ThHN, et al. Auxiliary partial liver transplantation for end-stage chronic liver disease. N Eng J Med 1988;319:1507-1511.
2. Metselaar HJ, Hesselink EJ, de Rave S, Groenland ThN, Bakker CM, Weimar W, et al. A comparison between heterotopic and orthotopic liver transplantation in patients with end-stage chronic liver disease. Transpl Proc 1991;23:1531-1532.
3. Hartley P, Petruckevitch A, Reeves B, Rolles K. The national liver transplantation audit: an overview of patients presenting for liver transplantation from 1994 to 1998. Br J Surg 2001; 88:52-58.
4. Gencoǧlu EA, Aktaş A, Emiroglu R, Karakayali H, Niron EA, Haberal M. Scintigraphic evaluation of graft and native liver function after heterotopic liver transplantation. Transpl Proc 2001;33:2858-2859.
5. Adam R, Cailliez V, Majno P, Karam V, McMaster P, Calne RY, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000;356:621-627.
6. Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Star 2001;55: 19-24.
7. Anselmo DM, Baquerizo A, Geevarghese S, Ghobrial RM, Farmer DG, Busuttil RW. Liver transplantation at Dumont-UCLA Transplant Center: experience with over 3,000 cases. Clin Transpl 2001;:179-186.
8. Azoulay D, Castaing D, Adam R, Savier E, Delvart V, Karam V, et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg 2001;233:565-574.
9. Broering DC, Topp S, Schaefer U, Fischer L, Gundlach M, Sterneck M, et al. Split liver transplantation and risk to the adult recipient: analysis using matched pairs. J Am Coll Surg 2002; 195:648-657.
10. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of a differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002;8:482-487.
11. Slooter GD, Marquet RL, Jeekel J, Ijzermans JNM. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor α. Br J Surg 1995;82: 129-132.